why choose us

First received: December 30, 2022

Clinical Trial: A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence

Study Status: Completed

Recruit Status: Completed

Condition: Stress Urinary Incontinence

Study Type: Interventional


Official Title: A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-exploration Phase II Trial to Evaluate the Efficacy and Safety of EG017 Tablets in Postmenopausal Women With Stress Urinary Incontinen

Brief Summary: The purpose of this study is to determine whether EG017 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.

Read more